Olorinab Clinical Trial

A Phase 2, multi-center, randomized, double-blind, placebo-controlled, 12-week study to evaluate the efficacy and safety of olorinab in Irritable Bowel Syndrome (IBS) patients experiencing abdominal pain

Patients may be able to take part in the clinical program if they*:

  • Are 18-70 years of age
  • Have been diagnosed with IBS with constipation or diarrhea (IBS-C or IBS-D)
  • Experience abdominal pain due to IBS

For more information please visit https://myibspainstudy.com/

*Other eligibility criteria apply

For more information please visit www.MyIBSPainStudy.com